Prelude Therapeutics (PRLD) Other Working Capital Changes (2024 - 2026)
Prelude Therapeutics' Other Working Capital Changes history spans 3 years, with the latest figure at $68000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 93.51% to $68000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $34.6 million, a 1943.29% increase, with the full-year FY2025 number at $35.5 million, changed N/A from a year prior.
- Other Working Capital Changes hit $68000.0 in Q1 2026 for Prelude Therapeutics, down from $34.4 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for PRLD hit a ceiling of $34.4 million in Q4 2025 and a floor of -$643000.0 in Q1 2024.
- Historically, Other Working Capital Changes has averaged $4.0 million across 3 years, with a median of $68000.0 in 2026.
- The widest YoY moves for Other Working Capital Changes: up 3659.83% in 2025, down 258.75% in 2025.
- Tracing PRLD's Other Working Capital Changes over 3 years: stood at $916000.0 in 2024, then surged by 3659.83% to $34.4 million in 2025, then tumbled by 99.8% to $68000.0 in 2026.
- Business Quant data shows Other Working Capital Changes for PRLD at $68000.0 in Q1 2026, $34.4 million in Q4 2025, and -$287000.0 in Q3 2025.